Last reviewed · How we verify
Chronic ulcerative proctitis
Approved treatments
- Cortone
- Rowasa · Meda Pharms
Rowasa works by blocking the production of prostaglandins, which are chemicals that cause inflammation in the rectum and colon. - MESA · Meda Pharms
- Cortef · Generic (originally Merck/Upjohn)
- Cortisol · University of Zurich
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Chronic ulcerative proctitis patent landscape — cliff calendar, originator estates, attackable patents
- Chronic ulcerative proctitis treatment landscape brief
- Chronic ulcerative proctitis treatment updates RSS
Frequently asked questions about Chronic ulcerative proctitis
What drugs treat Chronic ulcerative proctitis?
Tracked treatments include Cortone, Rowasa, MESA, Cortef, Cortisol.
What is the treatment for Chronic ulcerative proctitis?
Standard treatment for Chronic ulcerative proctitis includes Cortone, Rowasa, MESA, Cortef, Cortisol. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Chronic ulcerative proctitis patent cliff · Chronic ulcerative proctitis CI report
- Treatment: Cortone
- Treatment: Rowasa · Meda Pharms
- Treatment: MESA · Meda Pharms
- Treatment: Cortef · Generic (originally Merck/Upjohn)
- Treatment: Cortisol · University of Zurich
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing